-
1
-
-
17544401946
-
A new American Joint Committee on Cancer staging system for cutaneous melanoma
-
Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 2000;88:1484-91.
-
(2000)
Cancer
, vol.88
, pp. 1484-1491
-
-
Balch, C.M.1
Buzaid, A.C.2
Atkins, M.B.3
Cascinelli, N.4
Coit, D.G.5
Fleming, I.D.6
-
2
-
-
0028213810
-
Prognostic factors in thin cutaneous melanoma
-
Mansson-Brahme E, Carstensen J, Erhardt K, Lagerlof B, Ringborg U, Rutquist LE. Prognostic factors in thin cutaneous melanoma. Cancer 1994;73:2324-32.
-
(1994)
Cancer
, vol.73
, pp. 2324-2332
-
-
Mansson-Brahme, E.1
Carstensen, J.2
Erhardt, K.3
Lagerlof, B.4
Ringborg, U.5
Rutquist, L.E.6
-
3
-
-
0031739852
-
Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm)
-
Spatz A, Shaw HM, Crotty KA, Thompson JE, McCarthy SW. Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm). Histopathology 1998;33:406-13.
-
(1998)
Histopathology
, vol.33
, pp. 406-413
-
-
Spatz, A.1
Shaw, H.M.2
Crotty, K.A.3
Thompson, J.E.4
McCarthy, S.W.5
-
4
-
-
0033015462
-
Update of diagnostic and prognostic markers in cutaneous malignant melanoma
-
Reed JA, Albino AP. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Dermatol Clin 1999;17:631-43.
-
(1999)
Dermatol Clin
, vol.17
, pp. 631-643
-
-
Reed, J.A.1
Albino, A.P.2
-
5
-
-
0032794632
-
Cell cycle regulators: Mechanism and their role in aetiology, prognosis and treatment of cancer
-
Michalides RJAM. Cell cycle regulators: mechanism and their role in aetiology, prognosis and treatment of cancer. J Clin Pathol 1999;52:555-68.
-
(1999)
J Clin Pathol
, vol.52
, pp. 555-568
-
-
Michalides, R.J.A.M.1
-
6
-
-
0030866223
-
Multiple pathways control cell cycle growth and transformation overlapping and independent activities of p53 and p21
-
Cox LS. Multiple pathways control cell cycle growth and transformation overlapping and independent activities of p53 and p21. J Pathol 1997;183:134-40.
-
(1997)
J Pathol
, vol.183
, pp. 134-140
-
-
Cox, L.S.1
-
7
-
-
0030051787
-
Expression of cyclin D1 and p53 in various malignant skin tumours
-
Inohara S, Kitagawa K, Kitano Y. Expression of cyclin D1 and p53 in various malignant skin tumours. Dermatology 1996;192:94-8.
-
(1996)
Dermatology
, vol.192
, pp. 94-98
-
-
Inohara, S.1
Kitagawa, K.2
Kitano, Y.3
-
8
-
-
0030040533
-
Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma
-
Wang YL, Uhara H, Yamazaki Y, Nikaido T, Saida T. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma. Br J Dermatol 1996;134:269-75.
-
(1996)
Br J Dermatol
, vol.134
, pp. 269-275
-
-
Wang, Y.L.1
Uhara, H.2
Yamazaki, Y.3
Nikaido, T.4
Saida, T.5
-
9
-
-
0029044648
-
Expression of p53 protein in malignant melanoma: Clinicopathological and prognostic implications
-
Weiss J, Heine M, Korner B, Pilch H, Jung EC. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 1995;733:23-31.
-
(1995)
Br J Dermatol
, vol.733
, pp. 23-31
-
-
Weiss, J.1
Heine, M.2
Korner, B.3
Pilch, H.4
Jung, E.C.5
-
10
-
-
0031851739
-
Protein expression of the cell cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free interval
-
Florenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Hom R. Protein expression of the cell cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free interval. Am J Pathol 1998;153:305-12.
-
(1998)
Am J Pathol
, vol.153
, pp. 305-312
-
-
Florenes, V.A.1
Maelandsmo, G.M.2
Kerbel, R.S.3
Slingerland, J.M.4
Nesland, J.M.5
Hom, R.6
-
11
-
-
0029805005
-
Cyclin kinase inhibitor p21WAF/CIP1 in malignant melanoma: Reduced expression in metastatic lesions
-
Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Florenes VA. Cyclin kinase inhibitor p21WAF/CIP1 in malignant melanoma: reduced expression in metastatic lesions. Am J Pathol 1996;149:1813-22.
-
(1996)
Am J Pathol
, vol.149
, pp. 1813-1822
-
-
Maelandsmo, G.M.1
Holm, R.2
Fodstad, O.3
Kerbel, R.S.4
Florenes, V.A.5
-
12
-
-
0033067733
-
P21 (WAF1/CIP1) expression in stage I cutaneous melanoma: Its relationship with p53, cell proliferation and survival
-
Karjalainen JM, Eskelinen MJ, Kellokoski JK, Reinikainen M, Alhava EM, Kosma VM. P21 (WAF1/CIP1) expression in stage I cutaneous melanoma: its relationship with p53, cell proliferation and survival. Br J Cancer 1999;79:895-902.
-
(1999)
Br J Cancer
, vol.79
, pp. 895-902
-
-
Karjalainen, J.M.1
Eskelinen, M.J.2
Kellokoski, J.K.3
Reinikainen, M.4
Alhava, E.M.5
Kosma, V.M.6
-
13
-
-
0030958766
-
Overexpression of the cyclin-dependant kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma
-
Trotter MJ, Tang L, Tron VA. Overexpression of the cyclin-dependant kinase inhibitor p21 (WAF1/CIP1) in human cutaneous malignant melanoma. J Cutan Pathol 1997;24:265-71.
-
(1997)
J Cutan Pathol
, vol.24
, pp. 265-271
-
-
Trotter, M.J.1
Tang, L.2
Tron, V.A.3
-
14
-
-
0031594907
-
p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma
-
Funk JO, Schiller PL, Barrett MT, Wong DJ, Kind P, Sander CA. p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma. J Cutan Pathol 1998;25:291-6.
-
(1998)
J Cutan Pathol
, vol.25
, pp. 291-296
-
-
Funk, J.O.1
Schiller, P.L.2
Barrett, M.T.3
Wong, D.J.4
Kind, P.5
Sander, C.A.6
-
15
-
-
0033560166
-
p16INK4a inactivation is not frequent in uncultered sporadic cutaneous melanoma
-
Fujimoto A, Morita R, Hatta N, Takehara K, Takata M. p16INK4a inactivation is not frequent in uncultered sporadic cutaneous melanoma. Oncogene 1999;15:2527-32.
-
(1999)
Oncogene
, vol.15
, pp. 2527-2532
-
-
Fujimoto, A.1
Morita, R.2
Hatta, N.3
Takehara, K.4
Takata, M.5
-
16
-
-
0031669830
-
Mitotic cyclins and cyclin-dependant kinases in melanocytic lesions
-
Tran TA, Ross JS, Carlson JA, Mihm MC Jr. Mitotic cyclins and cyclin-dependant kinases in melanocytic lesions. Hum Pathol 1998;29:1085-90.
-
(1998)
Hum Pathol
, vol.29
, pp. 1085-1090
-
-
Tran, T.A.1
Ross, J.S.2
Carlson, J.A.3
Mihm Jr., M.C.4
-
17
-
-
0029783806
-
Nuclear morphomey, immunohistochemical staining with Ki67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanoma of the skin
-
Talve LA, Collan YU, Elkfors TO. Nuclear morphomey, immunohistochemical staining with Ki67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanoma of the skin. J Cutan Pathol 1996;23:335-43.
-
(1996)
J Cutan Pathol
, vol.23
, pp. 335-343
-
-
Talve, L.A.1
Collan, Y.U.2
Elkfors, T.O.3
-
18
-
-
0031748832
-
Mitotic rate and S-phase fraction as prognostic factor in stage I malignant melanoma
-
Karjalainen JM, Eselinen MJ, Nordling S, Lipponen PK, Alhava EM, Kosma VA. Mitotic rate and S-phase fraction as prognostic factor in stage I malignant melanoma. Br J Cancer 1998;77:1917-25.
-
(1998)
Br J Cancer
, vol.77
, pp. 1917-1925
-
-
Karjalainen, J.M.1
Eselinen, M.J.2
Nordling, S.3
Lipponen, P.K.4
Alhava, E.M.5
Kosma, V.A.6
-
19
-
-
0029007357
-
Cell proliferation markers in predicting metastases in malignant melanoma
-
Reddy VB, Gattuso P, Aranha G, Carson HJ. Cell proliferation markers in predicting metastases in malignant melanoma. J Cutan Pathol 1995;22:248-51.
-
(1995)
J Cutan Pathol
, vol.22
, pp. 248-251
-
-
Reddy, V.B.1
Gattuso, P.2
Aranha, G.3
Carson, H.J.4
-
20
-
-
0028894034
-
Bcl2 protein expression in cutaneous malignant melanoma and benign melanocytic naevi
-
Cerroni L, Soyer HP, Kerl H. Bcl2 protein expression in cutaneous malignant melanoma and benign melanocytic naevi. Am J Dermatopathol 1995;17:7-11.
-
(1995)
Am J Dermatopathol
, vol.17
, pp. 7-11
-
-
Cerroni, L.1
Soyer, H.P.2
Kerl, H.3
-
21
-
-
0029044648
-
Expression of p53 protein in malignant melanoma: Clinicopathological and prognostic implications
-
Weiss J, Heine M, Pilch H, Jung EG. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol 1995;133:21-3.
-
(1995)
Br J Dermatol
, vol.133
, pp. 21-23
-
-
Weiss, J.1
Heine, M.2
Pilch, H.3
Jung, E.G.4
-
22
-
-
0032735232
-
Survivin apoptosis: An interloper between cell death and cell proliferation
-
Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: An interloper between cell death and cell proliferation. Lab Invest 1999:79:1327-33.
-
(1999)
Lab Invest
, vol.79
, pp. 1327-1333
-
-
Altieri, D.C.1
Marchisio, P.C.2
Marchisio, C.3
-
23
-
-
0033119037
-
Hypoxia induced up-regulation of angiogenin in human premalignant melanoma
-
Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröker EB et al. Hypoxia induced up-regulation of angiogenin in human premalignant melanoma. Cancer Res 1999;59:1578-83.
-
(1999)
Cancer Res
, vol.59
, pp. 1578-1583
-
-
Hartmann, A.1
Kunz, M.2
Köstlin, S.3
Gillitzer, R.4
Toksoy, A.5
Bröker, E.B.6
-
24
-
-
0032887299
-
Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness
-
Kunz M, Hartmann A, Flory E, Tokso A, Koczan D, Thiessen HJ et al. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am J Pathol 1999;155:753-63.
-
(1999)
Am J Pathol
, vol.155
, pp. 753-763
-
-
Kunz, M.1
Hartmann, A.2
Flory, E.3
Tokso, A.4
Koczan, D.5
Thiessen, H.J.6
-
25
-
-
0033957167
-
T-cell recognition of melanoma-associated antigens
-
Castelli C, Rivoltini L, Andreola G, Renkvist N, Parmiani G. T-cell recognition of melanoma-associated antigens. J Cell Physiol 2000;182:323-31.
-
(2000)
J Cell Physiol
, vol.182
, pp. 323-331
-
-
Castelli, C.1
Rivoltini, L.2
Andreola, G.3
Renkvist, N.4
Parmiani, G.5
-
26
-
-
0032929939
-
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes
-
Ferrarini M, Imro MA, Sciorati C, Heltai S, Protti MP, Pellicari C et al. Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytes. Int J Cancer 1999;81:573-9.
-
(1999)
Int J Cancer
, vol.81
, pp. 573-579
-
-
Ferrarini, M.1
Imro, M.A.2
Sciorati, C.3
Heltai, S.4
Protti, M.P.5
Pellicari, C.6
-
27
-
-
0033839180
-
A comparative study of Fas and Fas-ligand expression during melanoma expression
-
Soubrane C, Mouawad R, Antoine EC, Verola O, Gil-Delgado M, Khayat D. A comparative study of Fas and Fas-ligand expression during melanoma expression. Br J Dermatol 2000;143:307-12.
-
(2000)
Br J Dermatol
, vol.143
, pp. 307-312
-
-
Soubrane, C.1
Mouawad, R.2
Antoine, E.C.3
Verola, O.4
Gil-Delgado, M.5
Khayat, D.6
-
30
-
-
0029831503
-
Matrix metalloproteinase-2 (72 KD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
-
Vaisanen A, Tuominen H, Kallionien M, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72 KD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996;180:283-9.
-
(1996)
J Pathol
, vol.180
, pp. 283-289
-
-
Vaisanen, A.1
Tuominen, H.2
Kallionien, M.3
Turpeenniemi-Hujanen, T.4
-
31
-
-
0032895321
-
Expression of collagenases-1 and 3 and their inhibitors TIMP-1 and 3 correlates with the level of invasion in malignant melanomas
-
Airola K, Karonen T, Vaalamo M, Lehti K, Kariniemi AL, Keski-Oja J et al. Expression of collagenases-1 and 3 and their inhibitors TIMP-1 and 3 correlates with the level of invasion in malignant melanomas. Br J Cancer 1999;80:733-43.
-
(1999)
Br J Cancer
, vol.80
, pp. 733-743
-
-
Airola, K.1
Karonen, T.2
Vaalamo, M.3
Lehti, K.4
Kariniemi, A.L.5
Keski-Oja, J.6
-
32
-
-
0033923006
-
Expression and activation of matrix metalloproteinases-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
-
Hofmann UB, Westphal JR, Zendman AJW, Becker JC, Ruiter D, Goos NP. Expression and activation of matrix metalloproteinases-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 2000;191:245-56.
-
(2000)
J Pathol
, vol.191
, pp. 245-256
-
-
Hofmann, U.B.1
Westphal, J.R.2
Zendman, A.J.W.3
Becker, J.C.4
Ruiter, D.5
Goos, N.P.6
-
33
-
-
0030884405
-
Expression of gelatinase B and the matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment lesions of the skin
-
van den Oord JJ, Paeme G, Opdenakker G, de Wolf-Peeters C. Expression of gelatinase B and the matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment lesions of the skin. Am J Pathol 1997;151:665-70
-
(1997)
Am J Pathol
, vol.151
, pp. 665-670
-
-
Van Den Oord, J.J.1
Paeme, G.2
Opdenakker, G.3
De Wolf-Peeters, C.4
-
34
-
-
0032911086
-
Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells
-
Takahashi K, Etoh H, Tananbe KK. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int J Cancer 1999;80:387-95.
-
(1999)
Int J Cancer
, vol.80
, pp. 387-395
-
-
Takahashi, K.1
Etoh, H.2
Tananbe, K.K.3
-
35
-
-
0032926177
-
Localisation of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44 mediated tumour invasion
-
Yu Q, Stamenkovic J. Localisation of matrix metalloproteinase-9 to the cell surface provides a mechanism for CD44 mediated tumour invasion. Genes 1999;13:35-4.
-
(1999)
Genes
, vol.13
, pp. 35-34
-
-
Yu, Q.1
Stamenkovic, J.2
-
36
-
-
0031780745
-
Moesin and CD44 expression in cutaneous melanocytic skin neoplasms
-
Ichikawa T, Masumoto J, Kaneko M, Saida T, Sagara J, Tanigushi S. Moesin and CD44 expression in cutaneous melanocytic skin neoplasms. Br J Dermatol 1998;138:763-8.
-
(1998)
Br J Dermatol
, vol.138
, pp. 763-768
-
-
Ichikawa, T.1
Masumoto, J.2
Kaneko, M.3
Saida, T.4
Sagara, J.5
Tanigushi, S.6
-
37
-
-
0029944661
-
Expression of CD44 variants isoforms in malignant melanoma
-
Seiter S, Shadendorf D, Herrmann K, Schneider M, Rosel M, Arch R et al. Expression of CD44 variants isoforms in malignant melanoma. Clin Cancer Res 1996;2:447-56.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 447-456
-
-
Seiter, S.1
Shadendorf, D.2
Herrmann, K.3
Schneider, M.4
Rosel, M.5
Arch, R.6
-
38
-
-
0029007805
-
Expression of CD44 splice variants in human cutaneous melanoma cell lines is related to tumour progression and metastatic potential
-
Manten-Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, Van Muijen GN et al. Expression of CD44 splice variants in human cutaneous melanoma cell lines is related to tumour progression and metastatic potential. Int J Cancer 1995;64:182-8.
-
(1995)
Int J Cancer
, vol.64
, pp. 182-188
-
-
Manten-Horst, E.1
Danen, E.H.2
Smit, L.3
Snoek, M.4
Le Poole, I.C.5
Van Muijen, G.N.6
-
39
-
-
0032413528
-
Cadherin/catenin complex in benign and malignant melanocytic lesions
-
Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W et al. Cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998;186:350-5.
-
(1998)
J Pathol
, vol.186
, pp. 350-355
-
-
Silye, R.1
Karayiannakis, A.J.2
Syrigos, K.N.3
Poole, S.4
Van Noorden, S.5
Batchelor, W.6
-
40
-
-
0025012050
-
Integrin distribution in malignant melanoma: Association of Β3 subunit with tumour progression
-
Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M et al. Integrin distribution in malignant melanoma: association of Β3 subunit with tumour progression. Cancer Res 1994;50:6757-64.
-
(1994)
Cancer Res
, vol.50
, pp. 6757-6764
-
-
Albelda, S.M.1
Mette, S.A.2
Elder, D.E.3
Stewart, R.4
Damjanovich, L.5
Herlyn, M.6
-
41
-
-
0030818746
-
The interaction of APC, E-cadherin and Βcatenin in tumour development and progression
-
Ilyas M, Tomlinson PM. The interaction of APC, E-cadherin and Βcatenin in tumour development and progression. J Pathol 1997;182:128-37.
-
(1997)
J Pathol
, vol.182
, pp. 128-137
-
-
Ilyas, M.1
Tomlinson, P.M.2
-
42
-
-
0034799321
-
Loss of beta-catenin expression associated with disease progression in malignant melanoma
-
Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001;145:210-6.
-
(2001)
Br J Dermatol
, vol.145
, pp. 210-216
-
-
Kageshita, T.1
Hamby, C.V.2
Ishihara, T.3
Matsumoto, K.4
Saida, T.5
Ono, T.6
-
43
-
-
0034492932
-
Reduced level of CD44 and hyaluronan associated with unfavourable prognosis in clinical stage I cutaneous melanoma
-
Karjalainen JM, Tammi RH, Eskelinen MJ, Agren VM, Parkkinen JJ, Alhava EM et al. Reduced level of CD44 and hyaluronan associated with unfavourable prognosis in clinical stage I cutaneous melanoma. Am J Pathol 2000;157:957-65.
-
(2000)
Am J Pathol
, vol.157
, pp. 957-965
-
-
Karjalainen, J.M.1
Tammi, R.H.2
Eskelinen, M.J.3
Agren, V.M.4
Parkkinen, J.J.5
Alhava, E.M.6
-
44
-
-
0030790353
-
High CD4-4 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival
-
Dietrich A, Tanczos E, Vanscheidt W, Schöpf E, Simon JC. High CD4-4 surface expression on primary tumours of malignant melanoma correlates with increased metastatic risk and reduced survival. Eur J Cancer 1997;33:926-30.
-
(1997)
Eur J Cancer
, vol.33
, pp. 926-930
-
-
Dietrich, A.1
Tanczos, E.2
Vanscheidt, W.3
Schöpf, E.4
Simon, J.C.5
-
45
-
-
0344731256
-
Integrin (v Β3 promotes M21 melanoma growth in human skin by regulating tumour cell survival
-
Petitclec E, Strömblad S, von Schalscha TL, Mitjans F, Piulats J, Montgomery AMP et al. Integrin (v Β3 promotes M21 melanoma growth in human skin by regulating tumour cell survival. Cancer Res 1999;59:2724-30.
-
(1999)
Cancer Res
, vol.59
, pp. 2724-2730
-
-
Petitclec, E.1
Strömblad, S.2
Von Schalscha, T.L.3
Mitjans, F.4
Piulats, J.5
Montgomery, A.M.P.6
-
46
-
-
0027043136
-
Tumour angiogenesis: A new, significant, and independent prognostic indicator of early stage melanoma
-
Weidner N, Folkman J, Pozza F, Belavicqua P, Allred E, Moore D et al. Tumour angiogenesis: a new, significant, and independent prognostic indicator of early stage melanoma. J Natl Cancer Inst 1992;84:1875-85.
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1875-1885
-
-
Weidner, N.1
Folkman, J.2
Pozza, F.3
Belavicqua, P.4
Allred, E.5
Moore, D.6
-
47
-
-
0026636356
-
Relation of neovascularization to metastatis of non-small-cell lung cancer
-
Macchiarini P, Fontanini G, Hardin M, Squartini F, Angletti C. Relation of neovascularization to metastatis of non-small-cell lung cancer. Lancet 1992;340:145-6.
-
(1992)
Lancet
, vol.340
, pp. 145-146
-
-
Macchiarini, P.1
Fontanini, G.2
Hardin, M.3
Squartini, F.4
Angletti, C.5
-
48
-
-
0027717345
-
Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma
-
Weidner N, Carrol P, Flax J, Blumenfeld W, Folkman J. Tumour angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-9.
-
(1993)
Am J Pathol
, vol.143
, pp. 401-409
-
-
Weidner, N.1
Carrol, P.2
Flax, J.3
Blumenfeld, W.4
Folkman, J.5
-
49
-
-
0028783602
-
Tumour vascularity is not a prognostic factor for malignant melanoma of the skin
-
Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T et al. Tumour vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995;147:1049-56.
-
(1995)
Am J Pathol
, vol.147
, pp. 1049-1056
-
-
Busam, K.J.1
Berwick, M.2
Blessing, K.3
Fandrey, K.4
Kang, S.5
Karaoli, T.6
-
50
-
-
0034854407
-
Vascular involvement in the prognosis of primary cutaneous melanoma
-
Kashani-Sabet M, Sagebiel RW, Ferreira CMM, Nosrati M, Miller JR. Vascular involvement in the prognosis of primary cutaneous melanoma. Arch Dermatol 2001;137:1169-73.
-
(2001)
Arch Dermatol
, vol.137
, pp. 1169-1173
-
-
Kashani-Sabet, M.1
Sagebiel, R.W.2
Ferreira, C.M.M.3
Nosrati, M.4
Miller, J.R.5
-
51
-
-
0028951043
-
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
-
Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1:27-32.
-
(1995)
Nat Med
, vol.1
, pp. 27-32
-
-
Holmgren, L.1
O'Reilly, M.S.2
Folkman, J.3
-
52
-
-
0031929106
-
Tumour vascularity, proliferation and apoptosis in human melanoma micrometastases and macrometastases
-
Barnhill R, Piepkorn MW, Cochran AJ, Flynn E, Karaoli T, Folkman J. Tumour vascularity, proliferation and apoptosis in human melanoma micrometastases and macrometastases. Arch Dermatol 1998;134:991-4.
-
(1998)
Arch Dermatol
, vol.134
, pp. 991-994
-
-
Barnhill, R.1
Piepkorn, M.W.2
Cochran, A.J.3
Flynn, E.4
Karaoli, T.5
Folkman, J.6
-
53
-
-
0035862187
-
Identification of the tumour metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome
-
Roymans D, Vissemberg K, DeJonghe Ch, Willems R, Engler G, Kimura N et al. Identification of the tumour metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome. Exptl Cell Res 2001;262:145-53.
-
(2001)
Exptl Cell Res
, vol.262
, pp. 145-153
-
-
Roymans, D.1
Vissemberg, K.2
DeJonghe, Ch.3
Willems, R.4
Engler, G.5
Kimura, N.6
-
54
-
-
0026457964
-
Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression
-
Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 1992;52:6088-91.
-
(1992)
Cancer Res
, vol.52
, pp. 6088-6091
-
-
Florenes, V.A.1
Aamdal, S.2
Myklebost, O.3
Maelandsmo, G.M.4
Bruland, O.S.5
Fodstad, O.6
-
55
-
-
0031056656
-
Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells
-
Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997;3:171-6.
-
(1997)
Nat Med
, vol.3
, pp. 171-176
-
-
Ledda, M.F.1
Adris, S.2
Bravo, A.I.3
Kairiyama, C.4
Bover, L.5
Chernajovsky, Y.6
-
56
-
-
0029164746
-
MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas
-
Ramsay JA, From L, Iscoe NA, Kahn HJ. MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas. J Invest Dermatol 1995;105:22-6.
-
(1995)
J Invest Dermatol
, vol.105
, pp. 22-26
-
-
Ramsay, J.A.1
From, L.2
Iscoe, N.A.3
Kahn, H.J.4
-
57
-
-
0031891403
-
Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
-
Sparrow LE, English DR, Taran JM, Heenan PJ. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 1998;20:12-6.
-
(1998)
Am J Dermatopathol
, vol.20
, pp. 12-16
-
-
Sparrow, L.E.1
English, D.R.2
Taran, J.M.3
Heenan, P.J.4
-
58
-
-
0031975083
-
Prognostic implications of p53 overexpression in cutaneous melanomas from sun-exposed and non-exposed sites
-
Essner R, Kuo CT, Wang H, Wen DR, Turner RR, Nguyen T et al. Prognostic implications of p53 overexpression in cutaneous melanomas from sun-exposed and non-exposed sites. Cancer 1998;82:309-16.
-
(1998)
Cancer
, vol.82
, pp. 309-316
-
-
Essner, R.1
Kuo, C.T.2
Wang, H.3
Wen, D.R.4
Turner, R.R.5
Nguyen, T.6
-
59
-
-
0032587495
-
p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
-
Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 1999;154:313-23.
-
(1999)
Am J Pathol
, vol.154
, pp. 313-323
-
-
Lloyd, R.V.1
Erickson, L.A.2
Jin, L.3
Kulig, E.4
Qian, X.5
Cheville, J.C.6
-
60
-
-
0030659080
-
Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma
-
Strauma O, Akselen LA. Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanoma. Int J Cancer 1997;74:535-9.
-
(1997)
Int J Cancer
, vol.74
, pp. 535-539
-
-
Strauma, O.1
Akselen, L.A.2
-
61
-
-
0034103810
-
Loss of nuclear p16 expression correlates with increased tumour cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
-
Strauma O, Sviland L, Akselen LA. Loss of nuclear p16 expression correlates with increased tumour cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. Clin Cancer Res 2000;6:1845-53.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1845-1853
-
-
Strauma, O.1
Sviland, L.2
Akselen, L.A.3
-
62
-
-
0035668485
-
Cyclin A expression in superficial spreading melanomas correlates with clinical outcome
-
Florenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R. Cyclin A expression in superficial spreading melanomas correlates with clinical outcome. J Pathol 2001;195:530-6.
-
(2001)
J Pathol
, vol.195
, pp. 530-536
-
-
Florenes, V.A.1
Maelandsmo, G.M.2
Faye, R.3
Nesland, J.M.4
Holm, R.5
-
63
-
-
0033822962
-
Levels of Cyclin D1 and D3 in malignant melanoma. Deregulated Cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
-
Florenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R. Levels of Cyclin D1 and D3 in malignant melanoma. Deregulated Cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Clin Cancer Res 2000;6:3614-20.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3614-3620
-
-
Florenes, V.A.1
Faye, R.S.2
Maelandsmo, G.M.3
Nesland, J.M.4
Holm, R.5
-
64
-
-
0035915806
-
Expression of Melan-A/Mart-1 antigen as a prognostic factor in primary cutaneous melanoma
-
Berset M, Cerottini JP, Guggisberg D, Romero P, Burri F, Rimoldi D et al. Expression of Melan-A/Mart-1 antigen as a prognostic factor in primary cutaneous melanoma. Int J Cancer 2001;95:73-7.
-
(2001)
Int J Cancer
, vol.95
, pp. 73-77
-
-
Berset, M.1
Cerottini, J.P.2
Guggisberg, D.3
Romero, P.4
Burri, F.5
Rimoldi, D.6
-
65
-
-
0029925375
-
Prognostic value of tumour infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
-
Clemente CG, Mihm MC, Bufalino R, Zurrida S, Colloni P, Cascinelli N. Prognostic value of tumour infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996;77:1303-10.
-
(1996)
Cancer
, vol.77
, pp. 1303-1310
-
-
Clemente, C.G.1
Mihm, M.C.2
Bufalino, R.3
Zurrida, S.4
Colloni, P.5
Cascinelli, N.6
-
66
-
-
0033009218
-
Thin cutaneous melanomas (< 1.5 mm). Identification of risk factors indicative of progression
-
Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. Thin cutaneous melanomas (< 1.5 mm). Identification of risk factors indicative of progression. Cancer 1999;85:1067-78.
-
(1999)
Cancer
, vol.85
, pp. 1067-1078
-
-
Massi, D.1
Franchi, A.2
Borgognoni, L.3
Reali, U.M.4
Santucci, M.5
-
68
-
-
0032982090
-
Osteonectin expression correlates with clinical outcome in thin cutaneous melanomas
-
Massi D, Franchi A, Borgognoni L, Reali UM, Santucci M. Osteonectin expression correlates with clinical outcome in thin cutaneous melanomas. Hum Pathol 1999;30:339-44.
-
(1999)
Hum Pathol
, vol.30
, pp. 339-344
-
-
Massi, D.1
Franchi, A.2
Borgognoni, L.3
Reali, U.M.4
Santucci, M.5
-
69
-
-
0029665802
-
Beta 3 integrin expression in melanoma predicts subsequent metastasis
-
Hicken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L, Das Gupta TK. Beta 3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 1996;63:169-73.
-
(1996)
J Surg Res
, vol.63
, pp. 169-173
-
-
Hicken, T.J.1
Farolan, M.2
Ronan, S.G.3
Shilkaitis, A.4
Wild, L.5
Das Gupta, T.K.6
-
70
-
-
0033952887
-
Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome
-
McDermott NC, Milburn C, Curran CM, Kay EW, Walsh CB, Leader MB. Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome. J Pathol 2000;190:157-62.
-
(2000)
J Pathol
, vol.190
, pp. 157-162
-
-
McDermott, N.C.1
Milburn, C.2
Curran, C.M.3
Kay, E.W.4
Walsh, C.B.5
Leader, M.B.6
-
71
-
-
0031772245
-
Prognostic factors for cutaneous melanoma
-
Wick MR. Prognostic factors for cutaneous melanoma. Am J Clin Pathol 1998;110:713-8.
-
(1998)
Am J Clin Pathol
, vol.110
, pp. 713-718
-
-
Wick, M.R.1
-
72
-
-
0035677699
-
High proliferative activity may predict early metastasis of thin melanoma
-
Frahm SO, Schubert C, Parwaresch R, Rudolph P. High proliferative activity may predict early metastasis of thin melanoma. Hum Pathol 2000;32:1376-81.
-
(2000)
Hum Pathol
, vol.32
, pp. 1376-1381
-
-
Frahm, S.O.1
Schubert, C.2
Parwaresch, R.3
Rudolph, P.4
-
73
-
-
0034038805
-
Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: An adjunct for recognition of the vertical growth phase in malignant melanoma
-
Kaleem Z, Lindt AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH et al. Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanoma. Mod Pathol 2000;13:217-22.
-
(2000)
Mod Pathol
, vol.13
, pp. 217-222
-
-
Kaleem, Z.1
Lindt, A.C.2
Humphrey, P.A.3
Sueper, R.H.4
Swanson, P.E.5
Ritter, J.H.6
-
74
-
-
0344301855
-
Stochastic relationship between the growth fraction and vascularity of thin malignant melanoma
-
Pierard GE, Pierard-Franchimont C. Stochastic relationship between the growth fraction and vascularity of thin malignant melanoma. Eur J Cancer 1997;33:1888-92.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1888-1892
-
-
Pierard, G.E.1
Pierard-Franchimont, C.2
-
75
-
-
0030893843
-
Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer
-
Isaacs JT. Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 1977;150:1511-21.
-
(1977)
Am J Pathol
, vol.150
, pp. 1511-1521
-
-
Isaacs, J.T.1
-
76
-
-
0035845511
-
Gene expression patterns of breast carcinoma distinguish subclasses with potential clinical implications
-
Sorlie T, Perou CM, Tibshrani R, AasT, Geisler S, Johnsen H et al. Gene expression patterns of breast carcinoma distinguish subclasses with potential clinical implications. Proc Natl J Acad Sci 2001;98:10869-74.
-
(2001)
Proc Natl J Acad Sci
, vol.98
, pp. 10869-10874
-
-
Sorlie, T.1
Perou, C.M.2
Tibshrani, R.3
Aas, T.4
Geisler, S.5
Johnsen, H.6
-
77
-
-
0034931807
-
Molecular markers of metastasis in squamous cell carcinoma
-
Elliwell TR. Molecular markers of metastasis in squamous cell carcinoma. J Pathol 2001;194:289-93.
-
(2001)
J Pathol
, vol.194
, pp. 289-293
-
-
Elliwell, T.R.1
-
78
-
-
0035874979
-
A novel N-ras mutation in malignant melanoma is associated with excellent prognosis
-
Demunter A, Ahmadian MR, Libbrecht L, Stas M, Bains M, Schiffzek K et al. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. Cancer Res 2001;61:4916-22.
-
(2001)
Cancer Res
, vol.61
, pp. 4916-4922
-
-
Demunter, A.1
Ahmadian, M.R.2
Libbrecht, L.3
Stas, M.4
Bains, M.5
Schiffzek, K.6
|